NCT02640287View on ClinicalTrials.gov

Expression of Ku70/XRCC6 in Waldenström's Macroglobulinemia

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 1, 2020

Study Completion Date

July 1, 2020

Conditions
Waldenström Macroglobulinemia
Interventions
BIOLOGICAL

Blood or bone marrow samples

Trial Locations (1)

54500

CHRU Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT02640287 - Expression of Ku70/XRCC6 in Waldenström's Macroglobulinemia | Biotech Hunter | Biotech Hunter